CREW has been at this sort of thing for years. I don't know if they have ever been successful in lobbying the SEC to take action, but I give them credit for trying.
The search for a partner for El Quevar goes back well over a year. Not surprising that this hasn't come to fruition given the PM market, but this can (and I believe will) turn on a dime. I believe El Quevar is being carried on the books at a small premium to land value, as are the other exploration-stage property assets.
And downgrades to hold from buy based on valuation. That was probably based on the short move above $1.40 yesterday. In any case, they are the only analyst currently covering the stock.
It interesting that the 12 month pps target does not include a write-up in assets that will occur when Valardena re-opens, which could be $4/5 per share. Maybe they are waiting for the mine to actually re-open before adjusting their valuation.
Sure you stand a chance. Plenty of longs on this board bought in the $2s and $3s, thanks to overzealous shorts. Just need to so your own DD and have patience.
Well said, Matese. Only comment is that anytime you involve lawyers and are creating contracts it takes time. I was recently on one side of a buyout transaction for a small, $23M business. Took a month to generate final contracts after final terms were agreed to.
Top Institutional Holders
Holder Shares % Out Value* Reported
Vanguard Group, Inc. (The) 13,269,260 3.41 53,342,425 Mar 31, 2014
FMR, LLC 9,960,968 2.56 40,043,091 Mar 31, 2014
BlackRock Fund Advisors 8,323,384 2.14 33,460,003 Mar 31, 2014
State Street Corporation 5,680,554 1.46 22,835,827 Mar 31, 2014
BlackRock Institutional Trust Company, N.A. 5,564,677 1.43 22,370,001 Mar 31, 2014
Greywolf Capital Management LP 4,778,749 1.23 19,210,570 Mar 31, 2014
BlackRock Advisors, LLC 2,402,148 0.62 9,656,634 Mar 31, 2014
Susquehanna International Group, LLP 2,062,042 0.53 8,289,408 Mar 31, 2014
Northern Trust Corporation 2,053,583 0.53 8,255,403 Mar 31, 2014
Creative Planning 1,989,630 0.51 7,998,312 Mar 31, 2014
Top Mutual Fund Holders
Holder Shares % Out Value* Reported
Fidelity Select Portfolios - Biotechnology 8,724,206 2.24 35,071,308 Mar 31, 2014
iShares NASDAQ Biotechnology ETF 4,379,429 1.13 17,605,304 Mar 31, 2014
Vanguard Small-Cap Index Fund 3,911,527 1.01 15,724,338 Mar 31, 2014
Vanguard Total Stock Market Index Fund 3,455,233 0.89 13,890,036 Mar 31, 2014
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF 3,111,495 0.80 12,508,209 Mar 31, 2014
Vanguard Small-Cap Growth Index Fund 2,899,006 0.75 11,654,004 Mar 31, 2014
iShares Russell 2000 ETF 2,545,372 0.65 10,232,395 Mar 31, 2014
Vanguard Extended Market Index Fund 1,867,287 0.48 9,709,892 Dec 31, 2013
Fidelity Advisor Biotechnology Fund 1,236,762 0.32 4,971,783 Mar 31, 2014
Master Value Opportunities LLC 1,234,725 0.32 4,963,594 Mar 31, 2014
'Go kick your dog baloon' LOL. Seriously, you are way over your head here. If your going to bash, find something interesting and unique. It helps with credibility.
Is that what they changed their name to after previous failures? What happened to Antigenics, that sounded alot better.
Bashing doesn't become you. You are much better at ignorant pumping where you have mindless minions that worship you, such as on the LQMT board.
You bet I do. Your 'bubble' comment indicates that you haven't completed any significant DD here. What do you think one of the big pharmas would be willing to pay for MNKD today?
And two oncology programs, a novel delivery platform and $10B worth of sales in inventory. You are better off sticking with your LQMT 'investment'.
If you want to get your feet wet, consider a biotech mutual fund. Spend some time learning about the companies that the fund invests in, do some independent research on each. Eventually you will learn what to look for, and more importantly what to avoid. Then pick a few companies to invest in on your own, small investments at first.
If you cannot perform the DD yourself to make an educated decision, I suggest not investing.